Clinical Application of Biochemical Modulation in Cancer Chemotherapy: Biochemical Modulation for 5–FU
- 1 January 1997
- journal article
- clinical trial
- Published by S. Karger AG in Oncology
- Vol. 54 (1) , 12-18
- https://doi.org/10.1159/000227740
Abstract
The addition of Uracil to Tegafur, a prodrug of 5-fluorouracil (5-FU), has been shown to enhance the antineoplastic effect of 5-FU while reducing the side effects attributed to 5-FU catabolism. StudieKeywords
This publication has 0 references indexed in Scilit: